A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

The drug contributes to a higher percentage of body-mass weight loss compared to previous weight-loss medications, and accomplishes this more quickly.

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to a preprint study. Researchers found that people prescribed semaglutide ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications ...

In a head-to-head study in the New England Journal of Medicine, people taking Zepbound, Wegovy, Zepbound led to greater weight loss.

Results from the phase 3b STEP UP trial showed that a higher dose of Wegovy® (semaglutide 7.2 mg) delivered 21% weight loss in people with obesity, with a third of participants losing 25% or more ...

Wegovy (semaglutide) is an FDA-approved medication for chronic weight management. Learn more about Wegovy, including how it works and potential risks.

In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men. What’s not clear is why.

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50 percent more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...